Bioventus Balance Sheet Health
Financial Health criteria checks 3/6
Bioventus has a total shareholder equity of $217.4M and total debt of $391.2M, which brings its debt-to-equity ratio to 179.9%. Its total assets and total liabilities are $794.2M and $576.8M respectively. Bioventus's EBIT is $20.5M making its interest coverage ratio 0.5. It has cash and short-term investments of $25.2M.
Key information
179.9%
Debt to equity ratio
US$391.24m
Debt
| Interest coverage ratio | 0.5x |
| Cash | US$25.17m |
| Equity | US$217.43m |
| Total liabilities | US$576.81m |
| Total assets | US$794.24m |
Recent financial health updates
Recent updates
Bioventus: Bullish On Path To Profitability
Jan 24Bioventus: Reiterating Buy Thesis Following Q2 Earnings
Sep 08Bioventus Non-GAAP EPS of $0.10 misses by $0.06, revenue of $140.3M beats by $1.97M
Aug 11Bioventus stock rises as FDA clears SonaStar Elite for use in tumor removal
Aug 03Bioventus: Strong Value Gap, Insulated Via Leading Market Share
Jun 14Bioventus: Thoughts After An Active First Year
Mar 29Bioventus records first commercial shipment of BITS Balance system
Apr 27Financial Position Analysis
Short Term Liabilities: BVS's short term assets ($265.9M) exceed its short term liabilities ($173.3M).
Long Term Liabilities: BVS's short term assets ($265.9M) do not cover its long term liabilities ($403.5M).
Debt to Equity History and Analysis
Debt Level: BVS's net debt to equity ratio (168.4%) is considered high.
Reducing Debt: BVS's debt to equity ratio has increased from 128.3% to 179.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable BVS has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: BVS is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 54.4% per year.